NIH-funded research NIH-funded research

A device to predict severe acute kidney injury

Official title: A Device for Detection of Acute Kidney Injury

Funded at Nephsmart LLC · NIH-10919989 · Data updated 2026-11-12

This study is working on a new device that can help doctors predict if patients are at risk of serious kidney problems by looking at certain proteins in their urine, making it easier to manage their care and improve their treatment.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNephsmart LLC
NIH-funded
Lab location1 site (Little Rock, United States)
Project startAugust 1, 2024
Project endJuly 31, 2025
Funding year2024
Award (this year)$274,415
NIH project number1R41DK138646-01A1
Project IDNIH-10919989 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients who are at risk of developing severe acute kidney injury, particularly those with mild to moderate AKI.

Less likely to help

Patients with no history of kidney issues or those who are not at risk for acute kidney injury may not benefit from this research.

What this research studies

This research focuses on developing a device that can predict the risk of severe acute kidney injury (AKI) in patients. By analyzing specific protein cleavage patterns in urine, the device aims to differentiate between patients who will experience severe AKI and those who will not. The approach involves creating a point-of-care test that can provide timely predictions, potentially improving patient management and treatment outcomes. The research is based on preliminary findings that suggest this method could be both sensitive and specific in identifying at-risk patients.

Why it matters

Potential benefit: If successful, this research could lead to earlier interventions for patients at risk of severe acute kidney injury, potentially reducing the need for dialysis and improving overall kidney health.

How similar studies have gone: Other research has shown promise in using biomarkers for predicting kidney injury, but this specific approach utilizing protein cleavage is novel.

Where this research is happening

  • Nephsmart LLC
    Little Rock, United States
    Active

Researchers

  • Principal investigator: Arthur, John M. — Nephsmart LLC
  • Study coordinator: Arthur, John M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.